EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages

Atsushi Yamashita iD, Yoshiya Ito, Mayuko Osada, Hiromi Matsuda, Kanako Hosono, Kazutake Tsujikawa, Hirotsugu Okamoto, Hideki Amano iD

International Journal of Molecular Sciences · 20.09.2024 · 25 (18) · 10107

DOI: 10.3390/ijms251810107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.09.2024. Verfasst von Atsushi Yamashita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan. Hauptthemen laut MEDLINE: Acute Lung Injury, Receptor Activity-Modifying Protein 1, Signal Transduction, Lipopolysaccharides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Integrative Research Program of the Graduate School of Medical Science at Kitasato University, Parents’ Association Grant of the Kitasato University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that induces cytokine hypersecretion. Receptor activity-modifying protein (RAMP) 1, a subunit of the calcitonin gene-related peptide (CGRP) receptor, regulates the production of cytokines. This study examined the role of RAMP1 signaling during lipopolysaccharide (LPS)-induced acute lung injury (ALI). LPS administration to wild-type (WT) mice depleted alveolar macrophages (AMs) and recruited monocyte-derived macrophages (MDMs) and neutrophils. RAMP1-deficient (RAMP1−/−) mice exhibited higher lung injury scores, cytokine levels, and cytokine-producing neutrophil infiltration. RAMP1-deficient AMs produced more cytokines in response to LPS than WT AMs. Adoptive transfer of RAMP1-deficient AMs to RAMP1−/− mice increased cytokine levels and neutrophil accumulation compared to the transfer of WT AMs. RAMP1−/− mice had reduced MDM recruitment and lower pro-inflammatory and reparative macrophage profiles. Cultured bone marrow (BM)-derived RAMP1-deficient macrophages stimulated with LPS showed decreased expression of pro-inflammatory and pro-repairing genes. CGRP administration to WT mice reduced cytokine production and neutrophil accumulation. These findings indicate that RAMP1 signaling mitigates LPS-induced ALI by inactivating AMs and promoting inflammatory and repair activities of MDMs. Targeting RAMP1 signaling presents a potential therapeutic approach for the treatment of ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryReceptor Activity-Modifying Protein 1Signal TransductionLipopolysaccharidesMacrophages, AlveolarCytokinesAnimalsMiceMice, Inbred C57BLMice, KnockoutMaleMacrophagesNeutrophils

Stichwörter der Autor:innen

RAMP1immunitymacrophagenerveneutrophil

Substanzen

Receptor Activity-Modifying Protein 1LipopolysaccharidesCytokinesRamp1 protein, mouse

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
  • Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.
  • Department of Pharmacology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.
  • Department of Emergency and Critical Care Medicine, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.
  • Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

ORCID-Profile: Atsushi Yamashita, Hideki Amano

Förderung

  • Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
  • Integrative Research Program of the Graduate School of Medical Science at Kitasato University
  • Parents’ Association Grant of the Kitasato University School of Medicine

Zitieren

APA

Yamashita, A., Ito, Y., Osada, M., Matsuda, H., Hosono, K., Tsujikawa, K., Okamoto, H., & Amano, H. (2024). RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages. International Journal of Molecular Sciences, 25(18), 10107. https://doi.org/10.3390/ijms251810107

Vancouver

Yamashita A, Ito Y, Osada M, Matsuda H, Hosono K, Tsujikawa K, et al. RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages. International Journal of Molecular Sciences. 2024;25(18):10107. doi:10.3390/ijms251810107

BibTeX
@article{Yamashita2024,
  author = {Yamashita, Atsushi and Ito, Yoshiya and Osada, Mayuko and Matsuda, Hiromi and Hosono, Kanako and Tsujikawa, Kazutake and Okamoto, Hirotsugu and Amano, Hideki},
  title = {RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {18},
  pages = {10107},
  doi = {10.3390/ijms251810107}
}
Kostenlos starten →